Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies

OBJECTIVE: To evaluate the outcomes of immunosuppressive therapy (IST) discontinuation in patients with neuromyelitis optica spectrum disorder (NMOSD) after a sustained remission period. METHODS: We retrospectively reviewed the medical records of 17 patients with antiaquaporin-4 antibody-positive NM...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su-Hyun, Jang, Hyunmin, Park, Na Young, Kim, Yeseul, Kim, So-Yeon, Lee, Min Young, Hyun, Jae-Won, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903808/
https://www.ncbi.nlm.nih.gov/pubmed/33622675
http://dx.doi.org/10.1212/NXI.0000000000000947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903808/
https://www.ncbi.nlm.nih.gov/pubmed/33622675
http://dx.doi.org/10.1212/NXI.0000000000000947

Ejemplares similares